Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ependymoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 321 Leukemia 148 Precursor Cell Lymphoblastic Leukemia-Lymphoma 142 Lymphoma 98 Myelodysplastic Syndromes 65 Lymphoma, Non-Hodgkin 58 Lymphoma, Mantle-Cell 52 Burkitt Lymphoma 52 Lymphoma, Large B-Cell, Diffuse 50 Recurrence 48 Congenital Abnormalities 40 Leukemia, Monocytic, Acute 37 Leukemia, Myelomonocytic, Acute 32 Leukemia, Erythroblastic, Acute 32 Hodgkin Disease 32 Lymphoma, Follicular 31 Leukemia, Megakaryoblastic, Acute 30 Leukemia, Myelomonocytic, Chronic 25 Lymphoma, Large-Cell, Immunoblastic 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Leukemia, Biphenotypic, Acute 24 Blast Crisis 23 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Myeloproliferative Disorders 17 Anemia, Refractory, with Excess of Blasts 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, B-Cell, Marginal Zone 16 Neoplasm, Residual 13 Leukemia, Myeloid, Chronic-Phase 13 Leukemia, Myeloid, Accelerated Phase 13

Interventions

Temozolomide 16 Magnetic Resonance Spectroscopy 8 Etoposide 8 Cyclophosphamide 8 Radiotherapy 7 Carboplatin 7 Filgrastim 6 Bevacizumab 6 Thiotepa 5 Radiation 4 Biopsy 4 sargramostim 3 etoposide phosphate 3 Surveys and Questionnaires 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Methotrexate 3 Irinotecan 3 Gadolinium DTPA 3 Cisplatin 3 Azacitidine 3 Automobiles 3 alovudine 2 Yoga 2 Topotecan 2 Thalidomide 2 Sirolimus 2 Proton Therapy 2 Mental Status and Dementia Tests 2 Melphalan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡